Humza Sulahria

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• Aflibercept 2 mg Biosimilar (aflibercept-ayyh, Pavblu): Experience of safety in clinical settings-APEX- safety study
  Ashish Sharma, Arshad M. Khanani, David A. Eichenbaum +57 more
  Eye 2026 DOI: 10.1038/s41433-026-04327-1
  +Save
• Visual and Anatomic Outcomes of Faricimab in Naïve Neovascular Age-Related Macular Degeneration with Subretinal Hemorrhage: A Multi-Centre Retrospective Analysis
  Clinical Ophthalmology 2026 DOI: 10.2147/OPTH.S589703
  +Save
• Real-World Outcomes in Eyes With Neovascular AMD Switched From Brolucizumab to Faricimab: A TRUCKEE Study Analysis
  American Journal of Ophthalmology 2025 DOI: 10.1016/j.ajo.2025.08.018
  +Save
• Subretinal Gene Therapy for Treatment of Retinal and Choroidal Vascular Diseases
  American Journal of Ophthalmology 2025 DOI: 10.1016/j.ajo.2024.12.002
  +Save
• Bilateral paracentral acute middle maculopathy associated with open mitral valve repair
  American Journal of Ophthalmology Case Reports 2025 DOI: 10.1016/j.ajoc.2025.102284
  +Save
• Emerging Treatment Options for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
  Hannah Khan, Aamir A Aziz, Humza Sulahria +6 more
  Clinical Ophthalmology 2023 DOI: 10.2147/OPTH.S367089
  +Save